Download presentation
Published byKai Odiorne Modified over 9 years ago
1
Fetal Health Surveillance (FHS) Part 2 – Electronic Fetal Monitoring*
Maternal Newborn Orientation Learning Module Reproductive Care Program of Nova Scotia, 2012 *FHS: Part 1 should be viewed prior to review of this module
2
References
3
Objectives Review skilled use of the electronic fetal monitor (EFM) during labour Risks/benefits of electronic fetal monitoring Indications Methods of electronic fetal monitoring Analysis, interpretation and classification of tracings Appropriate interventions in the event of atypical or abnormal tracings Communication and documentation
4
Risks/benefits Some association with a reduction in neonatal seizures; no difference in cerebral palsy or perinatal mortality in C-sections and operative vaginal births
5
SOGC Recommendation (2007)
‘The normal, healthy fetus is well-equipped to withstand the repeated, transient hypoxia associated with labour contractions.’ ‘Intermittent auscultation (IA) is the preferred method of fetal surveillance for healthy women without risk factors for adverse outcomes’. For those at risk for adverse outcomes, electronic fetal monitoring is advised.
6
Indications for using the EFM
Examples of risk factors for ‘adverse outcomes’: Antepartum maternal HDP Hemorrhage Diabetes Morbid Obesity Antepartum fetal Prematurity Oligohydramnios IUGR Multiple pregnancy
7
Indications for using the EFM
Examples of risk factors for ‘adverse outcomes’: Intrapartum maternal Prolonged ROM Postterm pregnancy > 42+0 Previous C/S Augmented/induced labour* Intrapartum fetal Meconium staining Abnormal FHR on auscultation *Augmentation continuous EFM * Induction EFM can be interrupted periodically once the infusion is stable, and provided there are no additional risks and the tracing has been normal
8
Methods of electronic fetal monitoring
9
Applying the external EFM
Leopold’s Maneuver
10
Internal Fetal Monitoring
IUPC Scalp electrode
11
Equipment - Monitor Paper
20 bpm 10 sec. 1 minute
12
Quality of the tracing – FHR
13
Quality of the tracing - contractions
Cont’n Cont’n
14
Features of the tracing
Contractions FH Baseline Variability Accelerations Decelerations
15
Contractions Estimate frequency from the start one contraction to the start of the next Duration estimated in seconds Estimate over 10 min Document range ‘q 2-3 min x sec’ Resting tone ‘soft’ or ‘firm’ by palpation; approx. 20 mmHg measured by IUPC frequency Resting tone
16
Abnormal contraction patterns
Tachysystole – more than 5 contractions in 10 minutes, averaged over 30 minutes Hypertonus – resting tone > 20 to 25 mmHg
17
Baseline FHR Approximate mean of the FHR (rounded to 5 bpm) assessed over 10 minutes Excludes accelerations and decelerations Normal baseline 110 to 160bpm
18
Tachycardia Causes: Prematurity Maternal anxiety/medication
Prolonged fetal activity Fever/infection Chronic fetal hypoxemia Baseline > 160 bpm x > 10 min
20
Bradycardia Causes: Postmaturity Fetal heart block Vagal stimulation
Fetal hypoxia/acidosis (late sign) Atypical if baseline 100 to 110 bpm; Abnormal if baseline < 100 bpm
22
Variability Refers to fluctuations in the baseline FHR
Occurs because of push and pull between sympathetic nervous system (pushes the FHR up) and parasympathetic nervous system (pulls the FHR down) Requires an intact, well functioning nervous system and oxygenated brain stem
23
Variability To determine variability:
120 150 180 90 To determine variability: Select a 1-minute section of the tracing Look at the amplitude/range of fluctuations Ensure there is a minimum of 2 fluctuations/cycles within the minute CMNRP Average # of cycles – 2 to 4/min Moderate variability (amplitude) – 6 to 25 bpm
24
Classification of variability
Absent – range undetectable Moderate bpm Minimal ≤ 5 bpm Marked > 25 bpm
25
Minimal or absent variability
Causes: Fetal sleep Prematurity Medications Hypoxia/acidemia Atypical – if ≤ 5 bpm x 40 to 80 min Abnormal – if ≤ 5 bpm x > 80 min
28
Marked Variability Causes: Uncertain etiology Mild hypoxia
Catecholamines Abnormal – if ≥ 25 bpm x > 10 minutes *rule out artifact
29
Accelerations Causes:
Normal response of a well-oxygenated, non- acidotic fetus to sympathetic stimulation or fetal activity If not spontaneous, may be elicited by fetal scalp stimulation Abrupt increases in the FHR at least 15 bpm above the baseline, lasting 15 sec to 2 min (> 32 weeks gestation)
30
Describe this tracing including features reviewed so far
32
Decelerations - Early ‘Mirror image’ of contractions Nadir of deceleration occurs with peak of contraction; FHR returns to baseline as the contraction ends Mechanism – vagal response from head compression Benign CMNRP
33
Decelerations - Late Gradual decrease in the FHR with nadir after peak of contraction and gradual return to baseline following the contraction Deceleration may be almost undetectable; nadir usually not more than 10 to 20 bpm below the baseline Mechanism – uteroplacental insufficiency CMNRP Chronic/Acute Conditions
34
Decelerations - Late
35
Decelerations - Late
36
Decelerations - Variable
120 150 180 90 100 25 50 75 Abrupt decrease in the FHR, at least 15 bpm below the baseline, lasting ≥ 15 seconds and < 2 minutes Uncomplicated variables have ‘shoulders’ – accelerations before and following decel Mechanism – cord compression CMNRP Normal if occasional; Atypical if repetitive (≥ 3)
37
Complicated variable decels
to < 70 bpm x > 60 seconds Loss of variability Slow return to baseline Baseline continues at a lower rate Prolonged secondary acceleration (overshoot) Biphasic Tachycardia or bradycardia CMNRP Overshoot Biphasic
39
Prolonged decelerations
In FHR ≥ 15 bpm below baseline (most often ≥ 30 bpm), lasting ≥ 2 min, < 10 min Possible causes include cord prolapse, hypertonus, uterine rupture, and sudden fetal descent
40
Rare, distinctive tracings
42
Classification of EFM Tracings (SOGC, 2007)
Parameter Normal Atypical Abnormal Baseline 110 to 160 bpm Bradycardia 100 to 110 bpm Tachycardia > 160 bpm x > 30 min to < 80 min Rising Baseline Bradycardia < 100 bpm Tachycardia >160 bpm x > 80 min Erratic baseline Variability 6 to 25 bpm ≤ 5 bpm x < 40 min ≤5 bpm x min. ≤ 5 bpm x > 80 min ≥ 25 bpm x > 10 min Sinusoidal Decelerations None or occasional uncomplicated variables Early decels Repetitive (≥ 3) uncomplicated variables Occasional lates Single prolonged > 2 min, < 3 min Repetitive (≥ 3) complicated variables Lates >50% of contractions Single prolonged >3, < 10 min Accelerations Spontaneous accelerations Accelerations with scalp stimulation No acceleration with fetal scalp stimulation Usually absent
43
Recommended actions Normal Atypical Abnormal Action
May interrupt EFM for periods up to 30 minutes if condition stable and oxytocin rate stable Further assessment required Review overall clinical situation; scalp pH may be obtained; prepare for delivery pH > 7.25 – continue monitoring; repeat scalp gas in 30 minutes if atypical or abnormal tracing persists pH 7.20 to repeat scalp gas in 30 minutes pH <7.20 – delivery is advised
44
Atypical/Abnormal Tracings
Clinical Evaluation is essential: Are there health, pregnancy or labour complications? What is the labour status and progress? Is labour spontaneous or induced? Is the fluid clear or meconium stained? Is this pattern an abrupt change? How was the earlier tracing?
45
Interventions in response to abnormal features
May be specific to the atypical/abnormal features, as appropriate Variable decelerations cord compression relieve pressure on the cord change maternal position consider V/E to assess for cord prolapse Tachycardia check maternal temperature promote intrauterine resuscitation
46
Interventions in response to abnormal features
Late decelerations uteroplacental insufficiency maximize uteroplacental blood flow left lateral maternal position promote intrauterine resuscitation Minimal/absent variability for > 40 minutes scalp stimulation to elicit accelerations
47
Promoting intrauterine resuscitation
Discontinue oxytocin Position change/left lateral position IV rate to improve hydration Modify breathing and pushing techniques (2nd stage) Administer oxygen at 8-10 l/min* *Prolonged use of oxygen should be avoided; its effectiveness varies depending on the clinical situation; increases fetal pO2 only slightly.
48
G1, 40 3/7 wks; SRM x 26 hours, spontaneous labour, 3 cm, ‘0’
50
G1 induced for HDP at 40 4/7 wks; 4 cm dilated, station ‘0’, strong contractions, meconium stained fluid
52
Communication Always keep the labouring woman informed of findings of FHS including rationale for interventions Effective, interprofessional communication is essential Suboptimal communication was identified as a ‘root cause’ in 72% of reported adverse outcomes
53
Communication tools SOGC recommends ‘CHAT’ C – Current Condition
H – History A – Assessment T – Treatment SBAR is commonly used in NS S – Situation B – Background A – Assessment R – Recommendation
54
Documentation-clear, concise, and accurate
Contraction pattern and details of the FHR q 15 to 30 minutes during active labour (q15 minutes when oxytocin running), and every 5 minutes during 2nd stage. Tracing interpretation/classification Actions undertaken to improve atypical or abnormal tracings Plan of care
55
Legal ‘protection’ Consistent terminology and classification
Regular interprofessional education and review of tracings Effective communication and complete documentation Consistent ‘times’ on a high quality tracing, in the partogram and throughout the record Each portion of the tracing labeled; do not circle or mark ‘suspicious’ findings but do note adjustment of transducers and/or tocodial
56
In summary Regular interprofessional education related to fetal health surveillance and electronic fetal monitoring is essential for all health care providers who care for labouring women. This education should promote consistent terminology and a common approach that is based on current SOGC guidelines and standards of care. Regular education related to EFM (and other methods of FHS) that includes recommended terminology, classification of tracingis essential
57
Thank you! We welcome your feedback. Please take a few moments to complete a short evaluation: If you have any questions, please contact the RCP office at or
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.